Share on StockTwits
 

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) major shareholder Francis Reynolds sold 25,000 shares of the stock on the open market in a transaction dated Friday, February 21st. The shares were sold at an average price of $2.23, for a total transaction of $55,750.00. Following the sale, the insider now directly owns 9,836,420 shares in the company, valued at approximately $21,935,217. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) opened at 2.234 on Monday. Invivo Therapeutics Holdings Corp has a 1-year low of $0.94 and a 1-year high of $6.20. The stock has a 50-day moving average of $2.28 and a 200-day moving average of $2.04. The company’s market cap is $175.9 million.

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc is a development-stage company. The Company is developing and commercializing technologies for the treatment of spinal cord injuries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.